BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33244751)

  • 1. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
    Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M
    Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis.
    Guraya S
    Int J Surg; 2018 Dec; 60():41-47. PubMed ID: 30336280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
    Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
    Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
    Liu T; Yin L; Yan G; Li C; Wang L
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic Value of Circulating miR-29 Family for Digestive System Malignancies: A Meta-Analysis.
    Zou S; Chen F; Zhang L; Liu C; Chen H
    Lab Med; 2024 Jan; 55(1):1-7. PubMed ID: 37172311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of circulating microRNAs for hepatocellular carcinoma.
    Yang Y; Zhu R
    Mol Biol Rep; 2014 Oct; 41(10):6919-29. PubMed ID: 25030834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-200 as potential diagnostic markers for colorectal cancer: meta-analysis and experimental validation.
    Peng Z; Zhu W; Dai J; Ju F
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):77-85. PubMed ID: 29808805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
    Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
    Liu T; Liu D; Guan S; Dong M
    Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinoma:a meta-analysis.
    Zhang H; Ding R; Chen D
    Biomarkers; 2021 Nov; 26(7):586-597. PubMed ID: 34266326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of screening tests for esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Wong MCS; Deng Y; Huang J; Bai Y; Wang HHX; Yuan J; Zhang L; Yip HC; Chiu PWY
    Gastrointest Endosc; 2022 Aug; 96(2):197-207.e34. PubMed ID: 35413332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of microRNA-628 for cancers.
    Li JH; Sun SS; Fu CJ; Zhang AQ; Wang C; Xu R; Xie SY; Wang PY
    J Cancer; 2018; 9(9):1623-1634. PubMed ID: 29760801
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
    Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
    PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
    Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
    Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.